NCT07312981Recruiting
The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations
The CPH-MBD Cohort - Substudy on Dietary History
Source: ClinicalTrials.gov · Last updated 31 Dec 2025
Brief summary (registry, in English)
The aim of the study is to assess the association between the calcium and phosphorus balance and the stage of kidney disease measured by creatinine clearence in patients with chronic kidney disease stage 4 and 5. The balance is measured a measurement between the recorded diatery intake and the urinary excretion. Additionally a comparison between image based diatery accessment and weighted records will be measured
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 17 Dec 2025
- Start date
- 15 Dec 2025
- Primary completion date
- 15 May 2026
- Lead sponsor
- University of Copenhagen
- Diseases
- Chronic kidney disease
- NCT number
- NCT07312981
What you commit to
- Study type: Observational
- Planned participants: 50
- From 15 Dec 2025 to the primary completion date, 15 May 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- A glomerular filtration rate of \<30 ml ml/min/1.73m2
- 18 years and above
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Herlev Hospital, Dept Nephrology Coordinator of this site? Confirm its status | Herlev | Denmark | Recruiting |
| Copenhagen University Hospital Herlev Coordinator of this site? Confirm its status | Herlev | Denmark | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.